HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GNC To Gain Broad R&D Pipeline From New Owner Royal Numico

This article was originally published in The Tan Sheet

Executive Summary

The acquisition of General Nutrition Companies by the Dutch conglomerate Royal Numico will give the Pittsburgh-based supplement retailer an extensive R&D foundation on which to develop original nutritional products. The agreement was announced July 5.

You may also be interested in...



Numico Consolidation Of Rexall, GNC Operations To Save $36 Mil.

Royal Numico expects to save $36 mil. after eliminating overlapping operations and inefficiencies from its Rexall Sundown and General Nutrition businesses.

MyoVive Heart Drink Available In New York GNC Stores; Expansion Planned

A series of clinical trials are being sponsored by Royal Numico's new Nutricia Supplements division to substantiate the cardiac benefits of the firm's new dietary supplement beverage MyoVive.

GNC Reorganization Focuses On Retailing; Mfg. To Fall Under New Unit

GNC is combining its retailing operations into a new unit called General Nutrition Centers, which falls under General Nutrition Corporation, Inc. in a revamped corporate structure, the firm announced June 13.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS140655

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel